Dolby Laboratories (DLB) Asset Writedowns and Impairment (2009 - 2026)

Dolby Laboratories (DLB) has reported Asset Writedowns and Impairment for 18 consecutive years, with $553000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Asset Writedowns and Impairment fell 10.08% year-over-year to $553000.0; the trailing twelve-month figure through Jun 2026 stood at $4.1 million (up 51.26% YoY), and the FY2025 full-year result was $2.4 million, up 207.89% from the prior year.
• Asset Writedowns and Impairment fell to $553000.0 in Q2 2026 per DLB's latest filing, from $2.9 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $16.9 million in Q3 2023 and bottomed at -$2.1 million in Q4 2023.
• Historically, Asset Writedowns and Impairment has averaged $1.4 million across 5 years, with a median of $631000.0 in 2024.
• The widest YoY moves for Asset Writedowns and Impairment: up 1132.34% in 2023, down 234.63% in 2023.
• Over 5 years, Asset Writedowns and Impairment stood at -$1.0 million in 2022, then slumped by 103.98% to -$2.1 million in 2023, then soared by 134.75% to $730000.0 in 2024, then rose by 8.49% to $792000.0 in 2025, then sank by 30.18% to $553000.0 in 2026.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $553000.0, $2.9 million, and $792000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.